Tower Research Capital (TRC)’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50
| Closed | -$277 | – | 6172 |
|
|
2024
Q3 | $277 | Sell |
50
-712
| -93% | -$7.21K | ﹤0.01% | 5401 |
|
|
2024
Q2 | $7.65K | Sell |
762
-236
| -24% | -$2.09K | ﹤0.01% | 4438 |
|
|
2024
Q1 | $9.01K | Sell |
998
-140
| -12% | -$1.03K | ﹤0.01% | 3917 |
|
|
2023
Q4 | $6.08K | Buy |
1,138
+171
| +18% | +$1.04K | ﹤0.01% | 4782 |
|
|
2023
Q3 | $7.14K | Buy |
+967
| New | +$7.45K | ﹤0.01% | 4501 |
|
|
2023
Q2 | – | Sell |
-1
| Closed | – | – | 6438 |
|
|
2023
Q1 | $0 | Sell |
1
-898
| -100% | -$5.96K | ﹤0.01% | 6430 |
|
|
2022
Q4 | $7K | Buy |
899
+128
| +17% | +$1.02K | ﹤0.01% | 4644 |
|
|
2022
Q3 | $5K | Sell |
771
-693
| -47% | -$5.28K | ﹤0.01% | 5186 |
|
|
2022
Q2 | $11K | Buy |
1,464
+416
| +40% | +$3.64K | ﹤0.01% | 4398 |
|
|
2022
Q1 | $12K | Buy |
1,048
+1,041
| +14,871% | +$21.1K | ﹤0.01% | 4112 |
|
|
2021
Q4 | $0 | Buy |
7
+5
| +250% | +$268 | ﹤0.01% | 6678 |
|
|
2021
Q3 | $0 | Buy |
2
+1
| +100% | +$67 | ﹤0.01% | 6275 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 5939 |
|
|
2021
Q1 | $0 | Sell |
1
-134
| -99% | -$27K | ﹤0.01% | 5806 |
|
|
2020
Q4 | $17K | Buy |
135
+8
| +6% | +$558 | ﹤0.01% | 3986 |
|
|
2020
Q3 | $8K | Sell |
127
-22
| -15% | -$2.28K | ﹤0.01% | 4202 |
|
|
2020
Q2 | $20K | Buy |
+149
| New | +$20.8K | ﹤0.01% | 3693 |
|
|
2019
Q3 | – | Sell |
-8
| Closed | -$3K | – | 4604 |
|
|
2019
Q2 | $3K | Buy |
+8
| New | +$4.71K | ﹤0.01% | 3182 |
|
Tower Research Capital (TRC)'s GHSI Position: Q4 2024 in Review
Tower Research Capital (TRC) sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2024, closing a stake of 50 shares — an estimated $277 sold.
Tower Research Capital (TRC) first reported a position in GHSI in Q2 2019 and held it in 18 quarters. The position peaked at $20K in Q2 2020. 0 funds tracked by Wall St. Rank hold GHSI as of Q4 2024.
- Tower Research Capital (TRC) reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 50 Guardion Health Sciences, Inc. Common Stock shares in Q4 2024, an estimated $277.
- Tower Research Capital (TRC) first reported a position in Guardion Health Sciences, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- Tower Research Capital (TRC)'s Guardion Health Sciences, Inc. Common Stock position peaked at $20K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.